DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2021

	March 31, 2021
Stock options outstanding		1,421,094
Deferred share units outstanding		72,142
Shares available for grant under the DiaMedica Therapeutics Inc. Omnibus Incentive Plan		1,050,026
Common shares issuable under common share purchase warrants		265,000
Total		2,808,262